Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Vered Stearns"'
Autor:
Ryan Rhome, Jean Wright, Lana De Souza Lawrence, Vered Stearns, Antonio Wolff, Richard Zellars
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeTo report outcomes on a subset of patients with triple negative breast cancer (TNBC) treated on prospective trials with post-lumpectomy partial breast irradiation and concurrent chemotherapy (PBICC) and compare them to a retrospectively assess
Externí odkaz:
https://doaj.org/article/7dcbe948edc74a0f857ddb59b69940ab
Autor:
Saranya Chumsri, Amanda Schech, Angela Brodie, Jane Lewis, Katherine Tkaczuk, Martin J. Edelman, Nancy Tait, Ting Bao, Vered Stearns
Publikováno v:
Clinical Oncology and Research. :1-12
Purpose: Considerable preclinical and clinical data indicate that only a small subset of tumor cells has longterm proliferating capacity. These cells are termed cancer stem cells (CSCs). Failure to eradicate CSCs is hypothesized to be a cause of canc
Autor:
Vered Stearns, Kristin J. Redmond, Christine Hodgdon, Lianne Kraemer, Natalie S. Joe, Daniele M. Gilkes
Publikováno v:
NPJ Breast Cancer
npj Breast Cancer, Vol 7, Iss 1, Pp 1-10 (2021)
npj Breast Cancer, Vol 7, Iss 1, Pp 1-10 (2021)
Breast cancer is the most commonly diagnosed cancer in women worldwide. Approximately one-tenth of all patients with advanced breast cancer develop brain metastases resulting in an overall survival rate of fewer than 2 years. The challenges lie in de
Autor:
Jennifer A. Schrack, Vered Stearns, Dina Lansey, David D. Celentano, Yasmin Baig, Lawrence J. Appel, Ahmed Hassoon, Seth S. Martin, Daniel Naimann
Publikováno v:
Circulation. 141
Importance: Physical Activity (PA) has numerous health benefits to cancer survivors, but motivation remains problematic. Coaching may increase PA and improve survivorship outcomes, but it is challenging to deliver personalized coaching at scale Objec
Autor:
Hanwen Wang, Richard J. Sové, Mohammad Jafarnejad, Sondra Rahmeh, Elizabeth M. Jaffee, Vered Stearns, Evanthia T. Roussos Torres, Roisin M. Connolly, Aleksander S. Popel
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 8 (2020)
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology
The survival rate of patients with breast cancer has been improved by immune checkpoint blockade therapies, and the efficacy of their combinations with epigenetic modulators has shown promising results in preclinical studies. In this prospective stud
Autor:
Judith O. Hopkins, William T. Barry, Cynthia A. Thomson, Patty Spears, Eric P. Winer, Pamela J. Goodwin, Electra D. Paskett, Catherine M. Alfano, Melinda L. Irwin, Clifford A. Hudis, Dawn L. Hershman, Marian L. Neuhouser, Linda M. Delahanty, Elizabeth S. Frank, Jennifer A. Ligibel, Olwen Hahn, Thomas A. Wadden, Vered Stearns, Vanessa Bernstein, Julia White
Publikováno v:
npj Breast Cancer, Vol 3, Iss 1, Pp 1-7 (2017)
NPJ Breast Cancer
NPJ Breast Cancer
Excess body weight is a poor prognostic factor in women with early breast cancer, but the effect of weight loss on the risk of breast cancer recurrence and mortality in women who are overweight or obese at the time of breast cancer diagnosis has not
Autor:
Cesar A. Santa-Maria, Vered Stearns, Elizabeth M. Jaffee, Jeff Wang, Leslie Cope, Christine Hodgdon, Ben Park, Natasha Hunter
Publikováno v:
Cancer Research. 81:OT-13
Background: Next-generation sequencing (NGS) is becoming increasingly routine in patients with advanced cancers, and rare mutations may occasionally be identified. Evaluating the efficacy of targeting rare mutations is challenging given the low obser
Autor:
Anna Maria Storniolo, Aditya Bardia, Cesar A. Santa-Maria, Vered Stearns, Claire F. Snyder, Antonio C. Wolff, Stacie Jeter, Anne Nguyen, Shannon Slater, Daniel F. Hayes, John H. Fetting, Katie Quinlan, Robert S. Miller, Roisin M. Connolly, Nora Lynn Henry, Gary L. Rosner, Jane Zorzi, Amanda L. Blackford
Publikováno v:
Breast cancer research and treatment. 171(1)
PURPOSE: Aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) are common adverse events of AIs often leading to drug discontinuation. We initiated a prospective clinical trial to evaluate whether bisphosphonates are associated with reduced
Autor:
Paul E. Goss, Lei He, Anne Renee Hartman, Steven E. Come, Karen Krag, Steven J. Isakoff, Kirsten Timms, Judy Garber, Darrel R. Borger, Paula D. Ryan, Eric P. Winer, Leif W. Ellisen, Minetta C. Liu, Dianne M. Finkelstein, Hope S. Rugo, Tiffany A. Traina, Vered Stearns, Erica L. Mayer, Lisa A. Carey
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 33, iss 17
Purpose The identification of patients with metastatic triple-negative breast cancer (mTNBC) who are expected to benefit from platinum-based chemotherapy is of interest. We conducted a single-arm phase II clinical trial of single-agent platinum for m
Autor:
Ben Ho Park, W. Brian Dalton, Christopher D. Gocke, Antonio C. Wolff, Patrick M. Forde, David M. Loeb, Roisin M. Connolly, Vered Stearns, James R. Eshleman, Christian F. Meyer, Cindy Geoghegan, Josh Lauring, Eric S. Christenson, Jennifer E. Axilbund, Jennifer Ensminger, Hyunseok Kang, Shannon Slater, Heather A. Parsons, Dana Petry, Christine A. Pratilas
Publikováno v:
JCO precision oncology, vol 2017, iss 1
Purpose Tumor genomic profiling for personalized oncology therapy is being widely applied in clinical practice even as it is being evaluated more formally in clinical trials. Given the complexities of genomic data and its application to clinical use,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3a75af812d25d1440b3be950602c0cf
https://escholarship.org/uc/item/6nz9n57x
https://escholarship.org/uc/item/6nz9n57x